For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
10
views
6
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      9
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Access in all areas? a round up of developments in market access and health technology assessment: part 4

      discussion

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this latest update, we look at recent developments in market access including the pricing agreement of Libmeldy ® by the Beneluxa Initiative, the financial impact of managed entry agreements in Italy and the restructuring of Agenzia Italiana del Farmaco (AIFA). We also highlight the collaboration between FINOSE and the New Expensive Drug (NED) section of the Nordic Pharmaceutical Forum.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: not found
          • Article: not found

          Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study

          Kristina Jenei, Adam J N Raymakers, Arnaud Bayle … (2023)
          Article 0 comments Cited 14 times – based on 0 reviews     Review now
          Article has an altmetric score of 95
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Financial Outcomes of Managed Entry Agreements for Pharmaceuticals in Italy

            Francesco Trotta, Maria Alessandra Guerrizio, Aurora Di Filippo … (2023)
            Key Points Question Are managed entry agreements (MEAs) important for the sustainability of pharmaceutical spending, and what are the financial outcomes of MEAs? Findings In this observational study of the financial outcomes of medicines with MEAs from 2019 to 2021 in Italy, the median proportion of payback to expenditure was 3.8%. Meaning These findings suggest that MEAs have limited importance for managing pharmaceutical expenditures; thus, prioritizing MEA use, identifying potential design changes, and improving implementation are valuable considerations.
            Article 0 comments Cited 3 times – based on 0 reviews     Review now
            Article has an altmetric score of 11
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Access in all areas? A round up of developments in market access and health technology assessment: part 1

              Ramiro Gilardino, Catrin Treharne, Silvy Mardiguian … (2023)
              In this new series reviewing recent developments in market access, we highlight publications investigating health technology assessment (HTA) guidance, review processes and outcomes across the world and discuss how forthcoming changes in the HTA and regulatory environment in the European Union may allow for more consistency in decision making.
              Article 0 comments Cited 3 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (nlm-ta): J Comp Eff Res
                Journal ID (iso-abbrev): J Comp Eff Res
                Journal ID (publisher-id): CER
                Title: Journal of Comparative Effectiveness Research
                Publisher: Becaris Publishing Ltd (Royston, UK )
                ISSN (Print): 2042-6305
                ISSN (Electronic): 2042-6313
                Publication date (Electronic, pub): 22 April 2024
                Publication date (Electronic, collection): June 2024
                Publication date PMC-release: 22 April 2024
                Volume: 13
                Issue: 6
                Electronic Location Identifier: e240060
                Affiliations
                [1 ]Lane Clark & Peacock LLP, London, W1U 1DQ, UK
                [2 ]Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK
                Author notes
                [* ]Author for correspondence: sreeram.ramagopalan@ 123456lcp.uk.com
                Article
                DOI: 10.57264/cer-2024-0060
                PMC ID: 11145526
                PubMed ID: 38647164
                SO-VID: 5f8d4e34-09f6-4d4b-8e21-8a42cc22f073
                Copyright © © 2024 The Authors
                License:

                This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License

                History
                Date received : 05 April 2024
                Date accepted : 10 April 2024
                Date: 22 April 2024
                Page count
                Pages: 5
                Categories
                Subject: Industry Update

                Keywords: aifa,agenzia italiana del farmaco,beneluxa initiative,eu hta,finose,health technology assessment,joint clinical assessment,managed entry agreements,market access,ned,new expensive drug
                Data availability:
                Keywords: aifa, agenzia italiana del farmaco, beneluxa initiative, eu hta, finose, health technology assessment, joint clinical assessment, managed entry agreements, market access, ned, new expensive drug

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content9

                See all similar

                Most referenced authors24

                See all reference authors